NASDAQ:NAMS | Insider Transactions — Page 3 | NewAmsterdam Pharma Co N.V.

NAMS Insider Transactions — Page 3

213 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–213; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
ForGrowth NAP B.V.TenPercentOwner2024-11-14Sale9,832.0$25.01
Forbion Capital Fund IV Cooperatief U.A.TenPercentOwner2024-11-13Sale1,066.0$25.0
Forbion Growth Opportunities Fund I Cooperatief U.A.TenPercentOwner2024-11-13Sale1,066.0$25.0
Forbion Growth Management B.V.TenPercentOwner2024-11-13Sale1,066.0$25.0
Forbion IV Management B.V.TenPercentOwner2024-11-13Sale1,066.0$25.0
ForGrowth NAP B.V.TenPercentOwner2024-11-13Sale1,066.0$25.0
Kooij Louise FrederikaChief Accounting Officer2024-10-01Sale45,000.0$15.72
Audet Juliette BerangereChief Business Officer2024-09-26Purchase1,104.0$15.7
Davidson Michael H.Chief Executive Officer2024-08-20Purchase5,000.0$16.27
Davidson Michael H.Chief Executive Officer2024-06-20Purchase5,000.0$17.26
Topper James NDirector2024-03-26Purchase8,429.0$21.5
Kastelein Johannes Jacob PieterChief Scientific Officer2024-03-26Sale190,476.0$21.5
LANGE LOUIS GDirector2024-02-13Purchase5,000.0$19.0